CDCRX
Price
$11.70
Change
+$0.03 (+0.26%)
Updated
Jul 31 closing price
Net Assets
25.27M
RIEBX
Price
$27.82
Change
-$0.03 (-0.11%)
Updated
Jul 31 closing price
Net Assets
145.28B
Interact to see
Advertisement

CDCRX vs RIEBX

CDCRX vs RIEBX Comparison Chart in %
View a ticker or compare two or three
VS
CDCRX vs. RIEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDCRX is a Buy and RIEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIEBX has more cash in the bank: 145B vs. CDCRX (25.3M). RIEBX pays higher dividends than CDCRX: RIEBX (2.96) vs CDCRX (0.00). CDCRX was incepted earlier than RIEBX: CDCRX (15 years) vs RIEBX (12 years). CDCRX (2.67) is less costly to investors than RIEBX (1.06). RIEBX is a more actively managed with annual turnover of: 65.00 vs. CDCRX (27.00). RIEBX has a lower initial minimum investment than CDCRX: RIEBX (250) vs CDCRX (1000). RIEBX annual gain was more profitable for investors over the last year : 8.57 vs. CDCRX (0.60). RIEBX return over 5 years is better than : 22.67 vs. CDCRX (-14.60).
CDCRXRIEBXCDCRX / RIEBX
Total Expense Ratio1.951.06184%
Annual Report Gross Expense Ratio2.671.06252%
Fund Existence15 years12 years-
Gain YTD6.2677.99978%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets25.3M145B0%
Annual Yield % from dividends0.002.96-
Returns for 1 year0.608.577%
Returns for 3 years-1.8533.01-6%
Returns for 5 years-14.6022.67-64%
Returns for 10 years-4.9653.30-9%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYNCX137.921.38
+1.01%
Rydex Nova C
AMGIX44.590.24
+0.54%
American Century Disciplined Value I
FEQNX15.880.08
+0.51%
Fidelity Advisor Hedged Equity M
ISTIX110.600.29
+0.26%
Nomura Science and Technology I
AIOOX12.23-0.01
-0.08%
Aristotle/Saul Global Equity I-2